Trials / Completed
CompletedNCT05878405
Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer
Methylene Blue Mouthwash for Oral Mucositis Pain in Cancer: An Open-Label, Non-Randomized, Controlled Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This phase III trial compares the effect of methylene blue mouthwash to standard of care mouthwash for the treatment of oral mucositis pain in patients with cancer. Using methlylene blue mouthwash may improve oral pain in patients with oral mucositis related to cancer and/or cancer treatments compared to usual standard of care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Anti-inflammatory/Antimicrobial/Analgesic Aqueous Mouth Rinse | Given PO |
| OTHER | Methylene Blue Oral Rinse | Given PO |
Timeline
- Start date
- 2023-06-06
- Primary completion
- 2024-12-06
- Completion
- 2024-12-06
- First posted
- 2023-05-26
- Last updated
- 2025-04-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05878405. Inclusion in this directory is not an endorsement.